US2021403497A1PendingUtilityA1
Processes and intermediates for the preparation of 1`-substituted carba-nucleoside analogs
Est. expirySep 21, 2029(~3.2 yrs left)· nominal 20-yr term from priority
Inventors:Thomas ButlerAesop ChoBenjamin R. GraetzChoung U. KimSamuel E. MetoboOliver L. SaundersAndrew W. WaltmanJie XuLijun Zhang
C07H 19/00C07H 19/23A61K 31/706A61K 31/7056C07H 1/00A61K 31/7052A61P 31/12C07H 19/04
70
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are processes and intermediates for the syntheses of nucleosides of pyrrolo[1,2-f][1,2,4]triazinyl and imidazo[1,2-f][1,2,4]triazinyl heterocycles of Formula I.
Claims
exact text as granted — not AI-modified1 . A method for preparing a compound of Formula I:
or an acceptable salt, thereof;
wherein:
R 1 is H, (C 1 -C 8 )alkyl, (C 4 -C 8 )carbocyclylalkyl, (C 1 -C 8 )substituted alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )substituted alkenyl, (C 2 -C 8 )alkynyl, (C 2 -C 8 )substituted alkynyl, or aryl(C 1 -C 8 )alkyl;
each R 2a or R 2b is independently H, F or OR 4 ;
each R 3 is independently (C 1 -C 8 ) alkyl, (C 1 -C 8 ) substituted alkyl, C 6 -C 20 aryl, C 6 -C 20 substituted aryl, C 2 -C 20 heterocyclyl, C 2 -C 20 substituted heterocyclyl, C 7 -C 20 arylalkyl, C 7 -C 20 substituted arylalkyl, (C 1 -C 8 ) alkoxy, or (C 1 -C 8 ) substituted alkoxy;
each R 4 or R 7 is independently H, optionally substituted allyl, —C(R 5 ) 2 R 6 , Si(R 3 ) 3 , C(O)R 5 , C(O)OR 5 , —(C(R 5 ) 2 ) m —R 15 or
or any two of R 4 or R 7 when taken together are —C(R 19 ) 2 —, —C(O)— or —Si(R 3 ) 2 (X 2 ) m Si(R 3 ) 2 —;
each R 15 is independently —O—C(R 5 ) 2 R 6 , —Si(R 3 ) 3 , C(O)OR 5 , —OC(O)R 5 or
each R 5 , R 18 or R 19 is independently H, (C 1 -C 8 ) alkyl, (C 1 -C 8 ) substituted alkyl, (C 2 -C 8 )alkenyl, (C 1 -C 8 ) substituted alkenyl, (C 1 -C 8 ) alkynyl, (C 1 -C 8 ) substituted alkynyl, C 6 -C 20 aryl, C 6 -C 20 substituted aryl, C 2 -C 20 heterocyclyl, C 2 -C 20 substituted heterocyclyl, C 7 -C 20 arylalkyl or C 7 -C 20 substituted arylalkyl;
each R 6 is independently C 6 -C 20 aryl, C 6 -C 20 substituted aryl, or optionally substituted heteroaryl;
each R a is independently H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, aryl(C 1 -C 8 )alkyl, (C 4 -C 8 )carbocyclylalkyl, —C(═O)R 11 , —C(═O)OR 11 , —C(═O)NR 11 R 12 , —C(═O)SR 11 , —S(O)R 11 , —S(O) 2 R 11 , —S(O)(OR 11 ), —S(O) 2 (OR 11 ), or —SO 2 NR 11 R 12 ;
X 1 is C—R 10 or N;
each X 2 is O or CH 2 ;
each m is 1 or 2;
each n is independently 0, 1 or 2;
each R 8 is halogen, NR 11 R 12 , N(R 11 )OR 11 , NR 11 NR 11 R 12 , N 3 , NO, NO 2 , CHO, CH(═NR 11 ), —CH═NHNR 11 , —CH═N(OR 11 ), —CH(OR 11 ) 2 , —C(═O)NR 11 R 12 , —C(═S)NR 11 R 12 , —C(═O)OR 11 , (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 4 -C 8 )carbocyclylalkyl, optionally substituted aryl, optionally substituted heteroaryl, —C(═O)(C 1 -C 8 )alkyl, —S(O) n (C 1 -C 8 )alkyl, aryl(C 1 -C 8 )alkyl, CN, OR 11 or SR 11 ;
each R 9 or R 10 is independently H, halogen, NR 11 R 12 , N(R 11 )OR 11 , N(R 11 )N(R 11 )(R 12 ), N 3 , NO, NO 2 , CHO, CN, —CH(═NR 11 ), —CH═NNH(R 11 ), —CH═N(OR 11 ), —CH(OR 11 ) 2 , —C(═O)NR 11 R 12 , —C(═S)NR 11 R 12 , —C(═O)OR 11 , R 11 , OR 11 or SR 11 ;
each R 11 or R 12 is independently H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 8 )carbocyclyl, (C 4 -C 8 )carbocyclylalkyl, optionally substituted aryl, optionally substituted heteroaryl, —C(═O)(C 1 -C 8 )alkyl, —S(O) n (C 1 -C 8 )alkyl, aryl(C 1 -C 8 )alkyl or Si(R 3 ) 3 ; or R 11 and R 12 taken together with a nitrogen to which they are both attached form a 3 to 7 membered heterocyclic ring wherein any one carbon atom of said heterocyclic ring can optionally be replaced with —O—, —S(O) n — or —NR a —; or R 11 and R 12 taken together are —Si(R 3 ) 2 (X 2 ) m Si(R 3 ) 2 —;
each R 20 is independently H, (C 1 -C 8 )alkyl, substituted (C 1 -C 8 )alkyl or halo;
wherein each (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl or aryl(C 1 -C 8 )alkyl of each R 1 , R 3 , R 4 , R 5 , R 6 , R 18 , R 19 , R 20 , R 11 or R 12 is, independently, optionally substituted with one or more halo, hydroxy, CN, N 3 , N(R a ) 2 or OR a ; and wherein one or more of the non-terminal carbon atoms of each said (C 1 -C 8 )alkyl is optionally replaced with —O—, —S(O) n — or —NR a —;
said method comprising:
(a) providing a compound of Formula II
or an acceptable salt thereof;
wherein R 16 is OH, OR 18 , —OC(O)OR 18 or —OC(O)R 18 ;
(b) treating the compound of Formula II with a cyanide reagent and a Lewis acid;
thereby forming the compound of Formula I;
provided that when the compound of Formula II is:
wherein X 1 is CH or N, R 1 is CH 3 , R 8 is NH 2 , and R 9 is NH 2 or H or;
wherein X 1 is CH, R 1 is CH 3 , R 8 is OH, and R 9 is NH 2 or;
wherein X 1 is CH, each R 1 and R 9 is H and R 8 is NH 2 ;
then said cyanide reagent is not (CH 3 ) 3 SiCN or said Lewis acid is not BF 3 —O(CH 2 CH 3 ) 2 .
2 . The method of claim 1 wherein the Lewis acid is (R 20 ) 3 CS(O) 2 OSi(R 3 ) 3 or a metal salt of (R 20 ) 3 CS(O) 2 OH;
at least two R 20 are halogen; and
said metal is selected from the group consisting aluminum, gallium, indium, thallium, tin, lead, bismuth, an alkaline earth metal, a transition metal and a lanthanide.
3 . The method of claim 2 wherein the compound of Formula I is a compound of Formula Ib:
or a salt thereof and the compound of Formula II is represented by Formula IIb:
or a salt thereof.
4 . The method of claim 3 wherein R 16 is —OH or OR 18 .
5 . The method of claim 4 wherein the compound of Formula Ib is represented by Formula Ic:
or a salt thereof and the compound of Formula IIb is represented by Formula IIc:
or a salt thereof.
6 . The method of claim 5 wherein each R 20 is F and the cyanide reagent is (CH 3 ) 3 SiCN.
7 . The method of claim 6 wherein the Lewis acid is CF 3 S(O) 2 OSi(CH 3 ) 3 or a metal salt of CF 3 S(O) 20 H wherein said metal is indium.
8 . The method of claim 7 wherein X 1 is CH.
9 . The method of claim 3 further comprising a method for preparing a compound of Formula IIb wherein R 16 is OH,
the method comprising:
providing a compound of Formula IIIb:
and treating the compound of Formula IIIb with an organometallic compound of Formula IV:
wherein M is MgX 3 or Li and X 3 is halogen;
thereby forming a compound of Formula IIb wherein R 16 is OH;
provided that when M is Li, the compound of Formula IIb is not a compound of Formula
wherein R 17 is OH; and
(a) X 1 is CH, R 1 is CH 3 , R 8 is NH 2 and R 9 is NH 2 or H; or
(b) X 1 is CH, R 1 is CH 3 , R 8 is OH and R 9 is NH 2 ; or
(c) X 1 is CH, each R 1 and R 9 is H and R 8 is NH 2 ; or
(d) X 1 is N, R 1 is CH 3 , R 8 is NH 2 , and R 9 is H, NH 2 or SCH 3 ; or
(e) X 1 is N, R 1 is CH 3 , R 8 is SCH 3 or NHCH 3 , and R 9 is SCH 3 ; or
(f) X 1 is N, R 1 is CH 3 , R 8 is OCH 3 , and R 9 is SCH 3 , SO 2 CH 3 or NH 2 .
10 . The method of claim 9 wherein M is MgX 3 .
11 . The method of claim 10 wherein X 1 is CH.
12 . The method of claim 9 further comprising a method of preparing a compound of Formula IV,
the method comprising:
providing a compound of Formula V:
wherein X 3 is Cl, Br or I and
treating the compound of Formula V with an organometallic reagent comprising an organomagnesium or organolithium compound;
thereby forming a compound of Formula IV.
13 . The method of claim 12 wherein the organometallic reagent comprises an organomagnesium compound.
14 .- 20 . (canceled)Join the waitlist — get patent alerts
Track US2021403497A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.